CLVLY Stock | News | Quote | Stock Forum | Sunday, October 6,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Clinuvel Pharmaceuticals Ltd. CLVLY Company Overview 

Stock Message Board http://investorshangout.com/search?q=CLVLY&am...mp;yt1=Go!

Last Updated: Sunday, October 6, 2013 12:12:39 PM

Clinuvel Pharmaceuticals Ltd. CLVLY Current Price and Quotes
Last Price 1.54
Previous Close 1.54 Open N/A
Daily Range N/A - N/A 52wk Range 2.95 - 1.51
Volume 0 Dividend N/A
Average Vol (3m) 5,876 Yield N/A
Clinuvel Pharmaceuticals Ltd. CLVLY
Company Information

Level 14
190 Queen Street
Melbourne, VIC 3000
Australia

Website: http://www.clinuvel.com
Phone: +61 3 9660 4900
Email: investorrelations@clinuvel.com

Clinuvel Pharmaceuticals Ltd. CLVLY
Clinuvel Pharmaceuticals Ltd is a global biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders. With our unique expertise in understanding the interaction of light and human skin, we have identified three groups of patients with a clinical need for photoprotection and another group with a need for repigmentation. These patient groups range in size from 10,000 to 45 million.

Clinuvel Pharmaceuticals Ltd. CLVLY
Financial Reportings and Disclosures

Reporting Status International Reporting: ASX - Australian Securities Exchange
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Philippe Wolgen CEO
Darren Keamy CFO
Colin Mackie Director, Bus. Dev.
Company Directors

Philippe Wolgen
Company Notes

Formerly=EpiTan Ltd. until 3-06
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Clinuvel Pharmaceuticals Ltd. CLVLY
CLVLY Security Details Other Company Securities

Share Structure

Market Value1 $46,787,833 a/o Oct 04, 2013
Shares Outstanding 30,381,710 a/o Dec 31, 2010
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Nov 03, 2006 Nov 07, 2006 Nov 16, 2006
Dividend (0.00308) Nov 03, 2006 Nov 07, 2006 Nov 16, 2006
Non US Stock Exchange Listing

CUV - ASX - Australian Securities Exchange - Qualified
Short Selling Data

Short Interest 17,236 (14.4%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon

Clinuvel Pharmaceuticals Ltd. CLVLY Financials
Data is unavailable at this time. Please check this page later.


Clinuvel Pharmaceuticals Ltd. CLVLY Recent News

CLVLY Clinuvel Pharmaceuticals Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CLVLY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CLVLY/quote
Stock Chart http://www.otcmarkets.com/stock/CLVLY/chart
Company Info http://www.otcmarkets.com/stock/CLVLY/company-info
Recent News http://www.otcmarkets.com/stock/CLVLY/news
Financials http://www.otcmarkets.com/stock/CLVLY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CLVLY/filings
Short Sales http://www.otcmarkets.com/stock/CLVLY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CLVLY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CLVLY/research
Summary http://finance.yahoo.com/q?s=CLVLY
Historical Prices http://finance.yahoo.com/q/hp?s=CLVLY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CLVLY
Basic Chart http://finance.yahoo.com/q/bc?s=CLVLY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CLVLY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CLVLY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CLVLY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CLVLY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CLVLY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CLVLY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CLVLY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CLVLY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CLVLY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CLVLY
Balance Sheet http://finance.yahoo.com/q/bs?s=CLVLY
Cash Flow http://finance.yahoo.com/q/cf?s=CLVLY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CLVLY
Market Watch http://www.marketwatch.com/investing/stock/CLVLY
Bloomberg http://www.bloomberg.com/quote/CLVLY:US
Morningstar http://quotes.morningstar.com/stock/s?t=CLVLY
Bussinessweek http://investing.businessweek.com/research/st...cker=CLVLY
Barchart http://www.barchart.com/quotes/stocks/CLVLY
OTC Short Report http://otcshortreport.com/index.php?index=CLVLY
Investopedia http://www.investopedia.com/markets/stocks/CLVLY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 11

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading
Concierge Hybrid Choice™: Transforming Patient Care

Updated Category News Views 22

A New Way to Nurture Patient Relationships This isn't just another cookie-cutter patient care program rolling out—it’s a genuine shake-up in the way doctors connect with their patients. Rishika Kaundal, MD, a dedicated family medicine physician, is pioneering change in Midlothian, Virginia with her Hybrid Choice™ concierge program. This isn't a fluff piece; it's a...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Blockchain Boom: Media Market to Hit $3.33B by 2035

Updated Category News Views 35

Blockchain is Not Just for Bitcoin Anymore Who would've thought, right? Blockchain's no longer just the playground for cryptocurrency enthusiasts. Today, it's making waves in the media and entertainment sector. Latest numbers from Credence Research have this market set to explode from $748 million in 2025 to a jaw-dropping $3.33 billion by 2035. Yeah, folks, that's a...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 24

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
Estrogen Patch Struggles: Menopause Care Needs a Boost

Updated Category News Views 25

Troublesome Estrogen Patch Shortages Hit Hard You'd think getting a prescription filled would be a simple task, right? Well, think again. Midi Health shines a glaring light on how the supposed ease of getting hormone therapy is anything but for many women in 2026. Out of those scrambling for estradiol patches, 44% hit roadblocks in pharmacies, and a third hit an all-out...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 4

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyzon Secures Major Order for Hydrogen Fuel Cell Trucks

Updated Category News Views 90

Hyzon Receives Order for Hydrogen Fuel Cell Electric Trucks Hyzon, an innovator in hydrogen fuel cell systems, has announced an exciting new order for two Fuel Cell Electric Trucks (FCETs). This marks a significant step for the company as it continues to provide sustainable solutions for refuse collection through advanced technology. The order comes from a reputable...

Continue Reading
Heron Therapeutics Reports Impressive Financial Gains for 2024

Updated Category News Views 362

Heron Therapeutics Achieves Remarkable Financial Results Heron Therapeutics, Inc. (Nasdaq: HRTX) has announced its outstanding financial performance for 2024, showcasing impressive results that highlight the company's strategic advancements within the biotechnology sector. The company reported a Q4 2024 GAAP net income of $3.6 million, leading to a profitable year-end...

Continue Reading
Imperative Logistics Group Enhances Next-Flight-Out Services

Updated Category News Views 327

Imperative Logistics Group Expands with DTH Expeditors Imperative Logistics Group has recently made a strategic move by acquiring DTH Expeditors, Inc., a prominent provider in high-touch domestic expedited services. This acquisition significantly enhances Imperative's capabilities in the next-flight-out (NFO) logistics sector, which is increasingly vital in today’s...

Continue Reading
Protecting Your Rights as a Five Below, Inc. Shareholder

Updated Category News Views 95

Understanding Your Rights as a Five Below, Inc. Shareholder As a shareholder, it’s crucial to understand your rights in the corporate landscape. Five Below, Inc. (NASDAQ: FIVE) is a well-known company, and being a shareholder means you have a stake in the success and governance of the organization. If you have been investing in its stocks for a significant period,...

Continue Reading
Jefferies Rates Endesa Shares As Hold with Price Target Insights

Updated Category News Views 53

Jefferies Initiates Coverage on Endesa with a Hold Rating Endesa, S.A. (ELE:SM) (OTC: ELEZY) recently came under the spotlight as Jefferies offered new coverage on the stock, assigning it a Hold rating. The analysts set a price target of EUR21.00, a value derived from the company's financial health and the evolving regulatory landscape in Spain. Jefferies emphasized that...

Continue Reading